Genomic characterization of high-risk non-muscle invasive bladder cancer
about
Opportunities of next-generation sequencing in non-muscle invasive bladder cancer outcome prediction.Progression to T1 High Grade (T1HG) from a Lower Stage/Grade is Associated with Poorer Survival Outcomes than Initial Diagnosis with T1HG Bladder Cancer.Therapeutic target discovery using Boolean network attractors: improvements of kali.Novel protein signatures suggest progression to muscular invasiveness in bladder cancer
P2860
Genomic characterization of high-risk non-muscle invasive bladder cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genomic characterization of high-risk non-muscle invasive bladder cancer
@en
Genomic characterization of high-risk non-muscle invasive bladder cancer.
@nl
type
label
Genomic characterization of high-risk non-muscle invasive bladder cancer
@en
Genomic characterization of high-risk non-muscle invasive bladder cancer.
@nl
prefLabel
Genomic characterization of high-risk non-muscle invasive bladder cancer
@en
Genomic characterization of high-risk non-muscle invasive bladder cancer.
@nl
P2093
P2860
P356
P1433
P1476
Genomic characterization of high-risk non-muscle invasive bladder cancer
@en
P2093
Alfred Rademaker
Benedito A Carneiro
Daniel T Oberlin
Francis J Giles
Joshua J Meeks
Julia Elvin
Kyle Fedorchak
Nike Beaubier
Sohail Balasubramanian
P2860
P304
75176-75184
P356
10.18632/ONCOTARGET.12661
P407
P50
P577
2016-11-01T00:00:00Z